Management believes that TSN’s diversified multi-protein, multi-channel portfolio ... Inc. price-consensus-eps-surprise-chart ...
Genascence Corporation ("Genascence"), a clinical-stage biotechnology company revolutionizing the treatment of prevalent ...
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced financial results and corporate updates from the third quarter ...
Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic ...
Third quarter Shareholder Letter provides updates on Benson Hill’s strategic transformation, sustainability approach, and ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Sylvamo , the world's paper company, is releasing third quarter 2024 earnings. Financial Highlights ? Third Quarter vs. Second Quarter Net income of $95 million ($2.27 per diluted share) vs. $83 ...